Everest Organics
Everest Organics Share Price Chart
Everest Organics last traded at ₹230.30 (2026-10-13). Over the past month the stock moved -16.3%, three months the stock moved -14.8%, year the stock moved -43.4%. Its closing range over 52 weeks is ₹215.65 – ₹522.50, with the latest close 55.9% below the high.
Closing prices up to 2026-10-13.
About Everest Organics
Incorporated in 1993, Everest Organics Ltd manufactures APIs and Intermediates.[1]
Product Profile: a) APIs:[1] Company has products for Gastroenterology, Hypercholesterolemia, Benign Prostatic, Anti Convulsant, Hypertrophy, Hyperuricemia and Gout, Anti Thrombotic, Anti Fungal, Anti Viral, Anti Emetics, Anti Diabetic, Insomnia, Skeletal muscle relaxant, Overactive Bladder, Rhino-Conjunctivitis, etc. b) Intermediates:[2] Febuxostat, Ilaprazole, Imatinib, Oseltamivir Phosphate, Abiraterone Acetate, Rivaroxaban, Itraconazole, Omeprazole, Pantoprazole, Rabeprazole, Esomeprazole, Pemetrexed, Pregabalin, Hydroxy, Chloro compound, Sulphide, Pyrazine, Gancyclovir, Apixaban, Aprepitant, Bilastine, etc. c) By Products:[2] Ammonium Sulphate, Sodium Nitrite, Di Sodium Orthophosphate, Di Ammonium Phosphate
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Everest Organics reported sales of ₹48.43 crore (-10.0%) and net profit of ₹1.11 crore (-21.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 48.43 | 4.33 | 8.94 | 1.11 | 1.14 |
| Mar 2026 | 48.75 | 6.70 | 13.74 | 2.63 | 2.71 |
| Dec 2025 | 42.59 | 3.54 | 8.31 | 0.36 | 0.37 |
| Sep 2025 | 51.00 | 5.13 | 10.06 | 1.16 | 1.19 |
| Jun 2025 | 53.81 | 4.44 | 8.25 | 1.41 | 1.45 |
| Mar 2025 | 40.93 | 3.44 | 8.40 | 2.91 | 3.00 |
| Dec 2024 | 42.05 | 4.02 | 9.56 | 1.14 | 1.42 |
| Sep 2024 | 44.05 | 3.43 | 7.79 | 0.74 | 0.92 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -10.9% | -19.9% | -22.2% | +65.8% | +15.8% | +1.3% | +19.1% | -10.0% |
| Operating profit growth | +26.6% | +43.6% | +16.6% | – | +49.6% | -11.9% | +94.8% | -2.5% |
| Net profit growth | +2366.7% | +5600.0% | +4750.0% | – | +56.8% | -68.4% | -9.6% | -21.3% |
| EPS growth | +2200.0% | +7000.0% | +3650.0% | – | +29.3% | -73.9% | -9.7% | -21.4% |
| OPM % | 7.8% | 9.6% | 8.4% | 8.3% | 10.1% | 8.3% | 13.7% | 8.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Everest Organics reported sales of ₹196.00 crore (+23.3%) and net profit of ₹6.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 196.00 | 20.00 | 10.00 | 6.00 | 5.72 |
| Mar 2025 | 159.00 | 7.00 | 5.00 | -1.00 | -1.33 |
| Mar 2024 | 197.00 | 11.00 | 6.00 | 0.00 | 0.18 |
| Mar 2023 | 183.00 | 1.00 | 1.00 | 0.00 | -0.22 |
| Mar 2022 | 200.00 | 6.00 | 3.00 | 1.00 | 1.42 |
| Mar 2021 | 182.00 | 23.00 | 13.00 | 14.00 | 17.15 |
| Mar 2020 | 167.00 | 19.00 | 12.00 | 11.00 | 13.62 |
| Mar 2019 | 156.00 | 18.00 | 11.00 | 8.00 | 9.39 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +39.3% | +7.1% | +9.0% | +9.9% | -8.5% | +7.7% | -19.3% | +23.3% |
| Operating profit growth | +157.1% | +5.6% | +21.1% | -73.9% | -83.3% | +1000.0% | -36.4% | +185.7% |
| Net profit growth | +300.0% | +37.5% | +27.3% | -92.9% | -100.0% | – | – | – |
| EPS growth | +338.8% | +45.0% | +25.9% | -91.7% | -115.5% | – | -838.9% | – |
| OPM % | 11.0% | 12.0% | 13.0% | 3.0% | 1.0% | 6.0% | 5.0% | 10.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Everest Organics.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Everest Organics.
Frequently Asked Questions
What is Everest Organics's current stock price?
Everest Organics shares were last quoted at ₹230.30 (-4.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Everest Organics?
Everest Organics has a price-to-earnings (P/E) ratio of 39.86 and a price-to-book (P/B) ratio of 2.73. The industry P/E is 52.82.
What is the 52-week high and low of Everest Organics?
The 52-week high of Everest Organics is ₹536.40 and the 52-week low is ₹197.00.
What is the market cap of Everest Organics?
The market capitalisation of Everest Organics is about ₹209.41 crore.
How did Everest Organics perform in its latest quarterly results?
In the latest quarter (Jun 2026), Everest Organics reported sales of ₹48.43 crore (-10.0%) and net profit of ₹1.11 crore (-21.3%), compared with the same quarter last year.
Is Everest Organics a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Everest Organics has a 3-year ROE of 2.00%, 3-year profit growth of 315.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Everest Organics?
Promoters hold about 59.60% of Everest Organics.
Which sector does Everest Organics belong to?
Everest Organics belongs to the Pharmaceuticals & Drugs sector.